Eye tracking and imaging features predicted uncertainty in manual brain tumor contours
Behavioral and image-derived features explained 39% of interobserver contour uncertainty during manual brain tumor delineation.
Behavioral and image-derived features explained 39% of interobserver contour uncertainty during manual brain tumor delineation.
CHAF1A supported homologous recombination and non-homologous end joining, while its depletion increased radiosensitivity in xenograft models.
Mean heart dose increased during esophageal IMPT, while heart-dose–triggered replanning reduced the excess dose in patients requiring adaptation.
Chemoradiotherapy suppressed LAMC2–macrophage signalling, while immunoradiotherapy enriched CCL5-positive CD8 T cells in preclinical esophageal squamous-cell carcinoma models.
More than 56,000 theoretically eligible European patients lived in areas with no proton access or critical capacity shortages in 2025.
An explainable model separated three-year local relapse rates of 11% versus 39%, but lacks independent external validation.
The model retained moderate discrimination for recurrence and metastasis, but predicted non-cancer death less reliably, especially in older patients.
In a randomized US survey, “radiation therapy” reduced selection of the same treatment by 8.3 percentage points versus “radiotherapy.”
A single 7 Gy fraction delivered 20–28 hours before hip arthroplasty produced similar heterotopic ossification rates to postoperative diclofenac.
Retroverted uterine position increased rectal and bowel dose during cervical brachytherapy, but survival, recurrence and severe toxicity remained comparable.
The OSCAR workflow delivered the first urgent or palliative fraction without planning CT in approximately 1 hour 50 minutes.
Synthetic CT artifacts were common during brain MR-only implementation, highlighting workflow QA and patient-selection issues not captured by controlled validation.
AI synthetic CT preserved soft-tissue HU and geometry well, while bone, air interfaces and implanted devices remained important failure modes.
NRS-RT showed 92.9% sensitivity and 97.2% specificity versus NRS-2002, but requires external validation before clinical adoption.
Single-fraction 22 Gy SRS achieved higher one-year local control than 20 Gy, although retrospective dose selection creates important confounding.